23andMe Confirms Merger with SPAC VG Acquisition Corp. (VGAC)

Go back to 23andMe Confirms Merger with SPAC VG Acquisition Corp. (VGAC)

23andMe to Merge with Virgin Group's VG Acquisition Corp. to Become Publicly-Traded Company Set to Revolutionize Personalized Healthcare and Therapeutic Development through Human Genetics

February 4, 2021 7:05 AM EST

SUNNYVALE, Calif. and NEW YORK, Feb. 4, 2021 /PRNewswire/ -- 23andMe, Inc., a leading consumer genetics and research company, and VG Acquisition Corp. (NYSE: VGAC), a special purpose acquisition company sponsored by Virgin Group, announced today that they have entered into a definitive merger agreement. Upon completion of the transaction, estimated in the second calendar quarter of 2021, VGAC will change its New York Stock Exchange (NYSE) ticker symbol, and the combined company's securities will trade under the ticker symbol "ME".

23andMe Overview

23andMe's mission is to help people access, understand and... More